Todd Christopher Longsworth, General Counsel at NovoCure Ltd (NVCR), sold 18,650 shares at $53.63 ($1.0M) on 2019-02-25, disclosed to the SEC on 2019-02-26.
Open-market sale of $1.0M NVCR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.63 | 9,325 | $500K | 50.0% |
| 2 | $53.63 | 9,325 | $500K | 50.0% |
| Total | $53.63 avg | 18,650 | $1.0M | 100% |
| Filing → |
| NVCR | SELL | 2021-03-10 | $629K | — | Filing → |
| NVCR | SELL | 2021-03-08 | $848K | — | Filing → |
| NVCR | SELL | 2021-03-04 | $716K | — | Filing → |